R. Horenstein

The CYP2C19*17 variant is not independently associated with clopidogrel response

J. O’Connell, A. Shuldiner, B. Mitchell, 2013, Journal of thrombosis and haemostasis : JTH.

Paraoxonase 1 (PON1) Gene Variants Are Not Associated With Clopidogrel Response

Haiqing Shen, A. Shuldiner, B. Mitchell, 2011, Clinical pharmacology and therapeutics.

Prospective Evaluation of Genetic Variation in Platelet Endothelial Aggregation Receptor 1 Reveals Aspirin‐Dependent Effects on Platelet Aggregation Pathways

M. Morrisey, P. Donnelly, R. Horenstein, 2017, Clinical and translational science.

POSTER SESSION II

M. Relling, R. Whaley, A. Motsinger-Reif, 2015, Pediatric Research.

Pharmacometabolomics Reveals That Serotonin Is Implicated in Aspirin Response Variability

A. Shuldiner, T. Hankemeier, R. Kaddurah-Daouk, 2014, CPT: pharmacometrics & systems pharmacology.

Pharmacogenetics and Clopidogrel Response in Patients Undergoing Percutaneous Coronary Interventions

A. Shuldiner, R. Horenstein, M. Vesely, 2011, Clinical pharmacology and therapeutics.

Identifying clinically relevant sources of variability: The clopidogrel challenge

L. Peletier, A. Shuldiner, L. Lesko, 2017, Clinical pharmacology and therapeutics.

The CYP2C19*17 variant is not independently associated with clopidogrel response

R. Horenstein, Jp P. Lewis, Sh H. Stephens, 2013, Journal of thrombosis and haemostasis : JTH.

Pharmacogenetics and Clopidogrel Response in Patients Undergoing Percutaneous Coronary Interventions

A. Shuldiner, R. Horenstein, M. Vesely, 2011, Clinical pharmacology and therapeutics.